Abstract
The effect of flurbiprofen (100 mg × 2 for 5 days) was compared with tranexamic acid (1.5 g × 3 for 3 days, 1 g × 2 days 4 and 5) in the treatment of 15 women with idiopathic menorrhagia. The mean blood loss during two medication-free periods was 295 ± 52 ml. A significant (p < 0.01) reduction in menstrual blood loss was recorded during treatment with both flurbiprofen and tranexamic acid. The menstrual blood loss was significantly (p < 0.01) lower during treatment with tranexamic acid (155 ± 33 ml) than with flurbiprofen (223 ± 44 ml). Various side effects were recorded by 7 of 15 women during treatment with tranexamic acid and by 4 women of 15 during treatment with flurbiprofen. Many women with menorrhagia suffer simultaneously from dysmenorrhea. Thus although tranexamic acid was generally more effective in reducing menstrual blood loss, flurbiprofen provides an important therapeutic alternative to antifibrinolytic agents, especially in patients with concomitant dysmenorrhea.